Home/Pipeline/Novo Nordisk Collaboration Program

Novo Nordisk Collaboration Program

Obesity Management

DiscoveryActive

Key Facts

Indication
Obesity Management
Phase
Discovery
Status
Active
Company

About Metaphore Biotechnologies

Metaphore Biotechnologies is a Flagship Pioneering-founded biotech utilizing a unique, computationally-driven platform called MIMIC™ to engineer small molecule therapeutics. The platform employs molecular mimicry and machine learning to create high-resolution pharmacophore maps, enabling the design of 'mimetic' compounds with programmed specificity, selectivity, and function. The company is in a pre-clinical, platform-validation stage, evidenced by a significant research collaboration with Novo Nordisk for next-generation obesity therapeutics, positioning it as a promising player in the targeted drug discovery space.

View full company profile

Therapeutic Areas

Other Obesity Management Drugs

DrugCompanyPhase
LPCN 2401LipocineNot Disclosed